151 related articles for article (PubMed ID: 27297724)
21. Expression of maspin predicts poor prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2002 Aug; 100(4):452-5. PubMed ID: 12115529
[TBL] [Abstract][Full Text] [Related]
22. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma.
Xia W; Lau YK; Hu MC; Li L; Johnston DA; Sheng Sj; El-Naggar A; Hung MC
Oncogene; 2000 May; 19(20):2398-403. PubMed ID: 10828881
[TBL] [Abstract][Full Text] [Related]
23. The roles of MASPIN expression and subcellular localization in non-small cell lung cancer.
Wang XF; Liang B; Zeng DX; Lei W; Chen C; Chen YB; Huang JA; Gu N; Zhu YH
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391558
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
25. Expression of maspin tumor suppressor and mTOR in laryngeal carcinoma.
Marioni G; Ottaviano G; Lovato A; Franz L; Bandolin L; Contro G; Giacomelli L; Alessandrini L; Stramare R; de Filippis C; Blandamura S
Am J Otolaryngol; 2020; 41(1):102322. PubMed ID: 31732312
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of cytoplasmic p27 in oral squamous cell carcinoma.
Vallonthaiel AG; Singh MK; Dinda AK; Kakkar A; Thakar A; Das SN
J Oral Pathol Med; 2016 Aug; 45(7):475-80. PubMed ID: 26750594
[TBL] [Abstract][Full Text] [Related]
27. Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.
Woenckhaus M; Bubendorf L; Dalquen P; Foerster J; Blaszyk H; Mirlacher M; Soler M; Dietmaier W; Sauter G; Hartmann A; Wild PJ
J Clin Pathol; 2007 May; 60(5):483-6. PubMed ID: 16698957
[TBL] [Abstract][Full Text] [Related]
28. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
[TBL] [Abstract][Full Text] [Related]
29. Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Maspin in NSCLC.
Katakura H; Takenaka K; Nakagawa M; Sonobe M; Adachi M; Ito S; Wada H; Tanaka F
Lung Cancer; 2006 Mar; 51(3):323-8. PubMed ID: 16406136
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L
Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.
Kinoshita T; Ohtsuka T; Yotsukura M; Asakura K; Goto T; Kamiyama I; Otake S; Tajima A; Emoto K; Hayashi Y; Kohno M
J Thorac Oncol; 2015 Apr; 10(4):619-28. PubMed ID: 25634009
[TBL] [Abstract][Full Text] [Related]
32. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
33. Maspin expression in stage I and II oral tongue squamous cell carcinoma.
Yasumatsu R; Nakashima T; Hirakawa N; Kumamoto Y; Kuratomi Y; Tomita K; Komiyama S
Head Neck; 2001 Nov; 23(11):962-6. PubMed ID: 11754500
[TBL] [Abstract][Full Text] [Related]
34. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
Kim S; Han J; Kim J; Park C
Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
[TBL] [Abstract][Full Text] [Related]
35. Aberrant Maspin mRNA Expression is Associated with Clinical Outcome in Patients with Pulmonary Adenocarcinoma.
Lu M; Li J; Huang Z; Du Y; Jin S; Wang J
Med Sci Monit; 2016 Jan; 22():134-9. PubMed ID: 26757744
[TBL] [Abstract][Full Text] [Related]
36. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications.
Lee DY; Park CS; Kim HS; Kim JY; Kim YC; Lee S
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):13-8. PubMed ID: 18091326
[TBL] [Abstract][Full Text] [Related]
37. MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: emerging evidence and therapeutic perspectives.
Marioni G; Staffieri C; Staffieri A; De Filippis C; Blandamura S
Acta Otolaryngol; 2009 May; 129(5):476-80. PubMed ID: 18615330
[TBL] [Abstract][Full Text] [Related]
38. Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.
Wakahara M; Sakabe T; Kubouchi Y; Hosoya K; Hirooka Y; Yurugi Y; Nosaka K; Shiomi T; Nakamura H; Umekita Y
Anticancer Res; 2017 Sep; 37(9):5071-5077. PubMed ID: 28870936
[TBL] [Abstract][Full Text] [Related]
39. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A
Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696
[TBL] [Abstract][Full Text] [Related]
40. Laryngeal carcinoma lymph node metastasis and disease-free survival correlate with MASPIN nuclear expression but not with EGFR expression: a series of 108 cases.
Marioni G; Staffieri A; Bertolin A; Giacomelli L; D'Alessandro E; Ottaviano G; Accordi D; Stramare R; de Filippis C; Blandamura S
Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1103-10. PubMed ID: 20052590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
